Ensign Peak Advisors
RVMD icon

Ensign Peak Advisors’s Revolution Medicines RVMD Stock Holding History

Ensign Peak Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.69M Sell
25,038
-202,902
-89% -$29.6M 0.01% 575
2026
Q1 		$22.2M Sell
227,940
-7,868
-3% -$794K 0.04% 290
2025
Q4 		$18.8M Sell
235,808
-12,670
-5% -$831K 0.03% 303
2025
Q3 		$11.6M Sell
248,478
-123,379
-33% -$4.83M 0.02% 425
2025
Q2 		$13.7M Sell
371,857
-55,609
-13% -$2.14M 0.02% 400
2025
Q1 		$15.1M Buy
427,466
+122,294
+40% +$4.96M 0.03% 365
2024
Q4 		$13.3M Buy
305,172
+265,389
+667% +$13.4M 0.02% 397
2024
Q3 		$1.8M Sell
39,783
-229,721
-85% -$10M ﹤0.01% 994
2024
Q2 		$10.5M Buy
269,504
+229,721
+577% +$8.59M 0.02% 438
2024
Q1 		$1.28M Sell
39,783
-2,007
-5% -$59.5K ﹤0.01% 1157
2023
Q4 		$1.2M Hold
41,790
– – ﹤0.01% 1239
2023
Q3 		$1.16M Hold
41,790
– – ﹤0.01% 1084
2023
Q2 		$1.12M Hold
41,790
– – ﹤0.01% 1171
2023
Q1 		$905K Hold
41,790
– – ﹤0.01% 1325
2022
Q4 		$995K Buy
41,790
+27,150
+185% +$577K ﹤0.01% 1163
2022
Q3 		$289K Buy
14,640
+2,650
+22% +$58.2K ﹤0.01% 1719
2022
Q2 		$234K Hold
11,990
– – ﹤0.01% 1745
2022
Q1 		$306K Buy
11,990
+840
+8% +$18.3K ﹤0.01% 1743
2021
Q4 		$281K Buy
+11,150
New +$314K ﹤0.01% 1838
2021
Q2 		– Sell
-32,413
Closed -$1.49M – 1852
2021
Q1 		$1.49M Hold
32,413
– – ﹤0.01% 1252
2020
Q4 		$1.28M Buy
32,413
+7,265
+29% +$287K ﹤0.01% 1290
2020
Q3 		$875K Buy
+25,148
New +$697K ﹤0.01% 1356

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Ensign Peak Advisors's RVMD Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Revolution Medicines (RVMD) stake by 89% in Q2 2026, selling an estimated $29.6M and leaving 25,038 shares worth $4.69M. The position accounts for 0.01% of the portfolio, ranked #575.

Ensign Peak Advisors first reported a position in RVMD in Q3 2020 and has held it in 22 quarters since. The position peaked at $22.2M in Q1 2026. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Ensign Peak Advisors held 25,038 shares of Revolution Medicines worth $4.69M as of Q2 2026.
  • Ensign Peak Advisors sold 202,902 Revolution Medicines shares in Q2 2026, an estimated $29.6M.
  • Revolution Medicines made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #575 holding.
  • Ensign Peak Advisors first reported a position in Revolution Medicines in Q3 2020 and has held it in 22 quarters since.
  • Ensign Peak Advisors's Revolution Medicines position peaked at $22.2M in Q1 2026.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.